The Moving Average Convergence Divergence (MACD) for NRSCF turned positive on December 09, 2024. Looking at past instances where NRSCF's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NRSCF advanced for three days, in of 2 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 136 cases where NRSCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where NRSCF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.533) is normal, around the industry mean (5.702). P/E Ratio (18.519) is within average values for comparable stocks, (34.442). NRSCF's Projected Growth (PEG Ratio) (0.713) is slightly lower than the industry average of (2.610). Dividend Yield (0.031) settles around the average of (0.030) among similar stocks. P/S Ratio (1.497) is also within normal values, averaging (112.495).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRSCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry InvestmentBanksBrokers
A.I.dvisor tells us that NRSCF and NMR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSCF and NMR's prices will move in lockstep.
Ticker / NAME | Correlation To NRSCF | 1D Price Change % | ||
---|---|---|---|---|
NRSCF | 100% | N/A | ||
NMR - NRSCF | 33% Poorly correlated | +0.70% | ||
CCORF - NRSCF | 20% Poorly correlated | -1.11% | ||
MQBKY - NRSCF | 18% Poorly correlated | -1.72% | ||
MCQEF - NRSCF | 6% Poorly correlated | N/A | ||
NPPTF - NRSCF | 5% Poorly correlated | +13.51% | ||
More |